Neuroprotection is a therapeutic strategy directed at keeping retinal ganglion cells (RGCs) alive and functional. This article discusses three commonly asked questions about neuroprotection and attempts to answer them in the context of our current understanding of the pathophysiology of RGC loss in glaucomatous optic neuropathy. © 2003 Elsevier Science Inc. All rights reserved.
Mendeley saves you time finding and organizing research
Choose a citation style from the tabs below